19th ICASA | 4 - 9 DEC 2017 | ABIDJAN | CÔTE D'IVOIRE
Click to Download ICASA 2017 Programme Book     :     Click to Download ICASA 2017 Pocket Programme     :     Click to Download ICASA 2017 Pocket Community Village     :    
ICASA 2017 Côte d'Ivoire > Track Description > Track C: Epidemiology and Prevention Science
Go Back

Track C: Epidemiology and Prevention Science


Description: This track will focus on HIV and AIDS prevention research and issues related to the design, implementation and evaluation of prevention programs to reach the SDG. It will include examination of Research, methodological and programmatic advances in the continuum of prevention, particularly best practices in HIV prevention for vulnerable populations in resource-limited settings. Strategies to put HIV prevention research into practice, efforts to promote preparedness for bio-medical prevention technologies, and research on new prevention approaches including microbicides, vaccines, pre- and post-exposure prophylaxis, circumcision and other methods will be presented. This Track will also address co-morbidities (Hepatitis, Tuberculosis, and STI’s, communicable end emerging diseases) and emerging.

Abstract Categories
Basic HIV Epidemiology

C1. Natural history of HIV
C2. HIV prevalence and incidence trends
C3 Trends in morbidity and mortality trends
C4. Risk factors for acquisition of HIV, geographic heterogeneity and contextual
C5 Epidemiology in general population including sero different couples
C6 Epidemiology of HIV in youth, adolescents and children
C7 HIV in most at risk populations (sex workers, MSM, prisoners, UD including PWID, migrants)

Epidemiology of HIV co‐morbidity and emerging diseases

C8. HIV and other sexually transmitted infections (STI)
C9. HIV and Tuberculosis co‐infection
C10. HIV and Malaria co‐infection
C11. HIV and Viral hepatitis
C12. HIV and non‐communicable diseases
C13. HIV and associated cancers
C14 HIV and other OI
C15 Epidemiology of emerging diseases

Social Epidemiology of HIV

C16. Sexual behavior, vulnerability and Most at Risk Populations (MARPS)
C17. Socio‐cultural and economic determinants of HIV
C18. Relapse of risky behaviours with the advent of ART

HIV/AIDS Surveillance and Monitoring and Evaluation

C19. Modeling HIV epidemic in the advent of ARTC
C20. HIV and AIDS surveillance: Routine, sentinel and second generation
C21. Surveillance of opportunistic infections, ART drug resistance
C22. Population‐based HIV sero epidemiologic studies, and measuring new HIV infections, including in children
C23. Monitoring and evaluation of HIV/AIDS programs

Methodological Issues and Capacity‐Building in Epidemiological and Prevention Research

C24. Novel research designs in HIV and AIDS
C25. Ethical and human rights issues in epidemiological and prevention research
C26. Measuring and modeling the impact of the HIV epidemic
C27. Methods aimed at measuring recent HIV infections and HIV incidence
C28. Surveillance systems and methods including geographical information system
C28 estimation of the size of KP

HIV/AIDS Prevention Programmes

C29. HIV testing services
C30. Elimination of Prevention of Mother to Child Transmission
C31. Prevention programmes in institutional and community settings
C32. Prevention programmes for immigrants, mobile and displaced populations
C33.Integrated prevention for PLHIV
C34. HIV Prevention technologies
C35. New approaches for HIV prevention
C36 Integrating HIV prevention into reproductive health, care, support and treatment programmes
C37 HIV Testing and diagnosis strategies

Diversified prevention tools:

C38 PeP
C39 PrEP
C40 TAsP
C41 Microbicides
C42 Ehealth

Leave a Comment or Questions

Time limit is exhausted. Please reload CAPTCHA.